A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

National Cancer Center, Goyang-si

Montefiore Einstein Center for Cancer Care, The Bronx

Charite Universitaetsmedizin Berlin, Berlin

CHU de la Timone, Marseille

Seoul National University Bundang Hospital, Seongnam

Hosp Univ A Coruna, A Coruña

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

ASST Grande Ospedale Metropolitano Niguarda, Milan

Gachon University Gil Hospital, Incheon

Virginia Cancer Specialists, Fairfax

Hosp Univ Fund Jimenez Diaz, Madrid

Hosp. Univ. 12 de Octubre, Madrid

Hosp. Univ. La Paz, Madrid

Chungbuk National University Hospital, Cheongju-si

Istituto Oncologico Veneto - IRCCS, Padua

University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham

Hosp. Virgen Macarena, Seville

Institut de cancerologie de l'ouest, Saint-Herblain

Universitaetsklinikum Essen, Essen

Hosp. Clinico Univ. de Valencia, Valencia

Ospedale S. Maria Delle Croci, Ravenna

Universitaetsklinikum Muenster, Münster

Universitaetsklinikum Koeln, Cologne

Chonnam National University Hwasun Hospital, Jeollanam-do

Institute Coeur Poumon, Lille

Nouvel Hopital Civil - CHU Strasbourg, Strasbourg

Fondazione G Pascale Istituto Nazionale Tumori IRCCS, Napoli

UCLA, Los Angeles

The Oncology Institute of Hope and Innovation, Cerritos

Beijing Cancer Hospital, Beijing

Shengjing Hospital Of China Medical University, Shenyang

Fudan University Shanghai Cancer Center, Shanghai

Shanghai Pulmonary Hospital, Shanghai

Yantai Yuhuangding Hospital, Yantai

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou

Chongqing University Cancer Hospital, Chongqing

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital Sun Yat sen University, Guangzhou

Huizhou Municipal Central Hospital, Huizhou

Sichuan Cancer Hospital, Chengdu

West China Hospital Sichuan University, Chengdu

The First Affiliated Hospital of Xian Jiaotong University, Xi'an

PERSONAL Oncologia de Precisao e Personalizada, Belo Horizonte

CIONC Centro Integrado de Oncologia de Curitiba, Curitiba

UPCO Unidade de Pesquisa Clinica em Oncologia, Pelotas

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS, Porto Alegre

Oncoclinicas Rio de Janeiro S A, Rio de Janeiro

Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro

Nucleo de Oncologia da Bahia, Salvador

Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo

Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo

The Ottawa Hospital Research Institute, Ottawa

Princess Margaret Cancer Centre University Health Network, Toronto

Klinikum Chemnitz gGmbH, Chemnitz

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden

Istituto Nazionale Tumori Regina Elena, Rome

National Hospital Organization Nagoya Medical Center, Nagoya

Shizuoka Cancer Center, Sunto Gun

The Cancer Institute Hospital of JFCR, Tokyo

Uniwersyteckie Centrum Kliniczne, Gdansk

INSTYTUT GENETYKI I IMMUNOLOGII GENIM Sp z o o, Lublin

Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw

Seoul National University Hospital, Seoul

Severance Hospital Yonsei University Health System, Seoul

Asan Medical Center, Seoul

Hosp. Gral. Univ. de Alicante, Alicante

Hosp. Del Mar, Barcelona

Hosp. Univ. Quiron Dexeus, Barcelona

Hosp Univ Vall D Hebron, Barcelona

Hosp Clinic de Barcelona, Barcelona

Gazi University Hospital, Ankara

Ankara Bilkent City Hospital, Ankara

Ankara Bilkent City Hospital, Çankaya

University College London Hospitals Nhs Foundation Trust, London

Imperial College London and Imperial College Healthcare NHS Trust, London

Sir Bobby Robson Cancer Trials Research Centre, Newcastle upon Tyne

Royal Marsden Hospital, Sutton